Introduction
============

Acute kidney injury (AKI), characterized by an abrupt decline of renal function, can be induced by numerous causes including renal ischemia reperfusion injury (IRI), nephrotoxic insults and infection of sepsis ([@B89]; [@B61]). Accumulating evidence shows that AKI is a global public health concern and a pivotal threat to human health, especially in hospitalized patients, as it impacts more than 13 million patients per year ([@B18]; [@B52]; [@B87]; [@B109]; [@B3]). Excessive inflammatory responses, oxidative stress, and the imbalance of the damage and repair of renal tubules, are all highly involved in the pathological process of AKI, however, specific targets and effective therapies are still lacking ([@B81]; [@B110]; [@B136]).

Traditional Chinese medicine (TCM) has been widely used for the treatment of AKI and its complications in China and neighboring countries, including Japan and Korea, for a long time. Some TCM-based therapies show good results and high efficacy in inhibiting inflammatory responses, programmed cell death and oxidative stress. In this regard, the therapeutic effects of TCMs have widely been tested in animal models of AKI and even in patients. For instance, the Xuebijing Injection is effective in improving clinical symptoms of sepsis-induced AKI patients after the Wenchuan Earthquake ([@B120]). Our recent study showed that wogonin not only protects cisplatin-induced AKI, but also preserves and even promotes the anti-tumor effect of cisplatin ([@B75]). However, it is noteworthy that some TCMs, such as aristolochic acids and other plant alkaloids, are nephrotoxic, ([@B106]). So, the application of TCM should be carefully evaluated.

In this paper, we reviewed the therapeutic effects of TCMs on AKI and the mechanism of action based on the assessment of evidence that supports hypotheses, additionally, TCMs with nephrotoxicity have also been discussed.

Applications of TCM in AKI
==========================

TCM Preparations in AKI
-----------------------

Until now, several TCM preparations have been tested in the treatment of AKI. There are shown in [Table 1](#T1){ref-type="table"}.

###### 

Application of TCM Preparations in the treatment of acute kidney injury.

  Names                 Origins                                                                                                                                                                                Models                               Function                     Mechanisms
  --------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------ ---------------------------- -----------------------------------------------------------------------------------
  A&A                   *Astragalus membranaceus* var. *mongholicus* and *Angelica sinensis*                                                                                                                   I/R-induced kidney injury            Decreasing cell necrosis     By inducing JNK ([@B8]; [@B74])
  DFD                   *Radix et Rhizoma Rhei*, *Radix Aconiti Lateralis Praeparata*, and *Radix et Rhizoma Asari*                                                                                            Adenine-induced renal injury         Inhibiting apoptosis         By blocking TGF-β1-JNK ([@B88])
  Xuebijing injection   *Radix paeoniae rubra*, *Chuan dome*, *Salvia miltiorrhiza*, *Safflower*, and *Chinese angelica*                                                                                       Serious scald-induced renal injury   Alleviating renal function   By suppressing HMGB1 ([@B94])
  HLJDD                 *Rhizoma coptidis* (*RC*), *Cortex phellodendri* (*CP*), *Radix scutellariae* (*RS*), and *Fructus gardenia*                                                                           LPS-induced AKI                      Attenuating apoptosis        Activating the Akt/HO-1 pathway and inhibiting NF-kB and MAPK activation ([@B55])
  ZDW                   *Cornus officinalis* Siebold & Zucc., *Radix Rehmanniae preparata*, *Dioscorea oppositifolia* L., *Cortex Phellodendri*, *rhizome*, *Moutan Cortex*, *Rhizoma Alismatis*, and *Wolf*   Gentamicin-induced renal injury      Attenuating apoptosis        By limiting caspase-3 activation ([@B41])
                                                                                                                                                                                                                                                                                 

### *Astragalus membranaceus* var. *mongholicus* and *Angelica sinensis* (A&A)

Decoctions of roots from A&A can improve renal blood flow in a murine model of acute ischemic renal injury, possibly by increasing NO production by activating eNOS and scavenging ROS, therefore accelerating renal repair after ischemic injury ([@B74]). Moreover, the therapeutic effect of A&A may be JNK-dependent ([@B8]).

### Dahuang Fuzi Decoction (DFD)

Dahuang Fuzi Decoction (DFD) consists of *Radix et Rhizoma Rhei*, *Radix Aconiti Lateralis Praeparata*, and *Radix et Rhizoma Asari*. Emerging evidence indicates that DFD attenuates adenine-triggered renal damage and tubular epithelial apoptosis, by blocking the activation of TGF-β1-JNK pathways ([@B88]).

### Xuebijing Injection

It consists of *chuan dome*, *radix paeoniae rubra*, *safflower*, *Salvia miltiorrhiza*, and *Chinese angelica*. Administration of a Xuebijing injection can suppress the production and release of high mobility group box-1 protein (HMGB1) in the kidney, thereby alleviating serious scald injury-induced AKI ([@B94]). In addition, an intravenous injection of Xuebijing attenuates the inflammatory response in AKI rats with paraquat poisoning ([@B102]). Importantly, Xuebijing improved the clinical symptoms of patients with sepsis-induced AKI after the Wenchuan Earthquake ([@B120]).

### Huang-Lian-Jie-Du-Decoction (HLJDD)

It is composed of *Rhizoma coptidis* (*RC*), *Cortex phellodendri* (*CP*), *Radix scutellariae* (*RS*), and *Fructus gardenia* by a weight ratio of 3:2:2:3. HLJDD effectively suppresses LPS-induced AKI by activating Akt/HO-1 pathway and inhibiting NF-κB and MAPK activation in mice ([@B55]).

### Zhibai Dihuang Wan (ZDW)

ZDW is a polyherbal formula mixed with *Rehmannia glutinosa* (Gaertn.) *DC*, *baked* (*Radix Rehmanniae preparata*), *Cornus officinalis* Siebold & Zucc., *Dioscorea oppositifolia* L., *Paeonia suffruticosa* Andrews, *Alisma plantago-aquatica* L., *rhizome* (*Rhizoma Alismatis*), and *Poria cocos* (Schw.) Wolf. ZDW has been used to treat chronic kidney diseases, like diabetic nephropathy, for many years. A recent study revealed that ZDW also protected against gentamicin-induced AKI both *in vivo* and *in vitro*, because it attenuated apoptosis of renal tubular epithelial cells by limiting caspase-3 activation ([@B41]).

TCM Monomers in AKI
-------------------

Compared with TCM preparations, TCM Monomers have recently attracted more attention in the treatment of diseases because they have certain molecular structures, clear mechanisms of action, predicted pharmacological effects and less drug-drug interactions. In the kidney, numerous TCM monomers have been applied in treating renal diseases including AKI caused by different stimuli. Therefore, we list TCMs that have comprehensively been studied to protect against AKI in recent years.

### Astaxanthin (ATX)

Astaxanthin (ATX) is a natural carotenoid extracted from marine organisms which are widely applied because of their strong antioxidant effect. Current studies demonstrate the renoprotective effects of ATX in many AKI models. ATX (5 mg/kg for 14 days via oral gavage) can improve I/R-induced AKI by exerting antioxidant activity and inhibiting tubular apoptosis/necrosis via scavenging free radicals ([@B78]). Moreover, ATX (40 mg/kg for 5 days by intraperitoneal injection) attenuated arsenic-induced AKI by fulfilling antioxidant functions and reducing As accumulation ([@B95]), and ATX (50 mg/kg for 12 h by gavage) ameliorated HgCl~2~-induecd AKI by exerting anti-oxidant activity and preventing lipid and protein oxidation ([@B6]). ATX (20 mg/kg 12 h via tail intravenous injection) consistently improved early AKI, following a severe burn, by modulating antioxidant activity and Akt/Bad/Caspases-mediated mitochondrial-apoptotic pathway ([@B38]).

### Baicalin

Baicalin is a *Scutellaria baicalensis*-derived flavonoid which has been tested in multiple types of AKI models. In clinical trials, Baicalin protects against AKI in pediatric sepsis by inhibiting renal cell apoptosis ([@B134]). In ischemia-reperfusion injured kidney, Baicalin (10 μmol/L for 24 h) exerts protective effects by inhibiting TLR2/4-mediated inflammation and mitochondrial stress-induced apoptosis of tubular epithelial cells ([@B44]). Administration of Baicalin (100 μmol/L) in HK-2 cells consistently reduced H~2~O~2~-induced cytotoxicity by activating downstream Nrf2 signaling and attenuating ER stress ([@B60]). These findings are supported by recent findings that Baicalin (50 mg/kg, i.p. for 2 weeks) prevents Lead (Pb)-induced renal injury and pediatric sepsis-induced AKI by blocking oxidative stress and apoptosis ([@B125]; [@B134]). Moreover, it is of note that baicalin is a novel PPAR-γ activator which may suppress NF-κB-mediated inflammation effectively ([@B58]).

### *Cordyceps sinensis* (CS)

*Cordyceps sinensis* (CS) is used as a tonic food which is derived from an entomogenous fungus ([@B131]). CS (5 g/kg via intragastric for 2 days) improves the outcome of I/R-induced AKI via different mechanisms including modulating SDF-1/CXCR4-signaling axis ([@B90]), up-regulating expression of HIF-1α, down-regulating the expression of NGAL ([@B118]) and reducing the expression level of TLR-4 ([@B130]). Moreover, treatment of CS (1.5 mg/200 μl) significantly alleviates stress responses and tissue damage by reducing autophagy and apoptosis in LPS-induced AKI ([@B99]). Additionally, CSP, as the mycelia glycoproteins of *Cordyceps sobolifera*, significantly suppresses cyclosporine A (CsA)-induced apoptosis and protects against nephron loss via increasing magnesium reabsorption ([@B19]).

### Epigallocatechin Gallate (EGCG)

As a major component of green tea, EGCG is famous for its anti-inflammatory and anti-apoptotic properties. EGCG, as a potent inducer of HO-1, can suppress renal injury by reducing oxidative stress and inflammation in several AKI models induced by contrast (EGCG 20 mg/kg intravenously) ([@B34]), I/R (EGCG 50 mg/kg i.p. for 24 h) ([@B71]) and cisplatin (EGCG 100 mg/kg i.p. for 12 days) ([@B80]), respectively. Furthermore, underlying mechanisms have extensively been explored in cisplatin nephropathy, EGCG (100 mg/kg i.p. for 2 days) prevented activation of ERK, the NF-κB pathway and caspase-12 while down-regulating the Fas-conducted extrinsic pathway and Bcl-2/Bax ratio, thereby reducing the apoptosis of tubular epithelial cells ([@B135]; [@B12]; [@B77]).

### Ginsenoside Rd (GSRd)

Ginsenoside Rd (GSRd) is isolated from the root of *Panax ginseng* and applied to protect cells in various types of diseases especially ischemia diseases ([@B113]). It is noteworthy that GSRd has an impact on different cell types which are involved in AKI. For instance, previous studies identified that GSRd (50 mg/kg i.p. for 2 days) prevented M1 macrophage polarization in I/R-injured kidney ([@B79]). Additionally, GSRd (5 mg/kg i.p. for 30 days) protected proximal tubule cells against I/R model-induced hypoxia-reoxygenation by inhibiting oxygen free radicals from attacking cell membranes ([@B116]). The renoprotective effect of GSRd (5 mg/kg i.p. for 30 days) was further determined in cisplatin and glycerol-induced AKI models, treatment of GSRd decreased apoptosis-triggered DNA fragmentation and oxidative stress ([@B115]; [@B114]; [@B128]). Other Ginsenosides, such as Rb1, Rg1 (80 mg/L for 24 h) and Rg3 also proved to be effective in the treatment of AKI. It has been identified that administration of Ginsenoside Rb1 relieves apoptosis of HK-2 cells in response to serum from I/R AKI ([@B132]). Ginsenoside Rg1 reduces aldosterone-induced oxidative stress and abnormal autophagy correlates with AMPK/mTOR pathway. Ginsenosides 20(S)-Rg3 exerts therapeutic effects in both cisplatin (GSRd 250 μg/mL for 24 h) and LPS (GSRd 10 mg/kg i.p. for 15 days)-induced AKI by targeting JNK-p53-caspase-3 axis and NF-κB signaling pathway ([@B47]; [@B91]; [@B39]).

### Resveratrol (RSV)

Resveratrol (RSV), a popular natural phenolic compound which is abundant in wines and grape skins, protects against multiple types of AKI due to its low toxicity, powerful antioxidants, and anti-inflammatory properties. Resveratrol (100 mg/kg for 20 h by oral gavage) can attenuate LPS-induced AKI by suppressing inflammation and apoptosis driven by macrophages ([@B16]). Resveratrol (10 mg/kg i.p. for 12 h) consistently protects against sepsis-induced tubular epithelium injury by restoring the renal microcirculation and scavenging reactive nitrogen species ([@B40]). In addition, resveratrol (3 mg/kg for 6 days via the forearm vein) ameliorates arsenic trioxide (As~2~O~3~)-induced nephrotoxicity by antagonizing oxidative stress and facilitating arsenic metabolism ([@B119]). Moreover, resveratrol is proven to be an anti-inflammatory agent in glycerol (RSV 25 mg/kg/day for 4 days via gastric intubation)- and cisplatin (RSV 25 mg/kg/day i.p. for 2/5 days)-induced AKI ([@B22]; [@B23]). Furthermore, previous studies demonstrated that resveratrol-mediated activation of SIRT1 improved cisplatin (RSV 10 mg/kg orally once a day for 7 days)-induced AKI by deacetylating p53 and reducing apoptosis ([@B50]), and RSV also inhibited sepsis (RSV 10 mg/kg i.p. for 3 days)-induced AKI and renal inflammation through NF-κB de-acetylation ([@B31]) or SIRT3-mediated deacetylation of SOD2 ([@B104]). Resveratrol (30 mg/kg i.p. for 12 h) protected against early sepsis-induced AKI by inhibiting the endoplasmic reticulum stress (IRE1)-activated NF-κB pathway ([@B92]). A previous study showed that RSVA405 (3 mg/kg i.p. for 24 h) and RSVA314 (3 mg/kg i.p. for 24 h), two biologically active resveratrol analogs (RSVAs), attenuated I/R-induced AKI by exerting anti-oxidative and anti-inflammatory effects, indicating that RSV and its derivatives may be promising agents to prevent and/or treat AKI with high efficiency ([@B49]).

### Tetramethylpyrazine (TMP)

Tetramethylpyrazine (TMP) is a natural product isolated from the Chinese herb *Ligusticum wallichii* Franch., which is famous for its antioxidative and anti-inflammatory effects. Previous studies showed that treatment with TMP protects against arsenic (TMP 100 μM for 6 h)-induced nephrotoxicity by targeting HO-1 and ARS2, which was further evidenced by the findings that TMP (20 mg/kg/day i.p. for 7 days) relieves gentamicin-induced AKI by enhancing Hax-1 mitochondrial localization in HO-1-dependent mechanisms ([@B84]; [@B36]). Additionally, by suppressing ROS production and the consequential inflammatory response, TMP protected against cisplatin (80 mg/kg/day orally for 7 days) or arsenic (100 μM for 24 h)-induced AKI ([@B1]; [@B35]). Moreover, a recent study showed that TMP (80 mg/kg/day i.p. for 4 days) suppressed the apoptosis of renal cells by targeting FoxO1, a pro-apoptotic transcription factor, to prevent contrast-induced AKI ([@B37]). Interestingly, TMP exerted a renoprotective role by downregulating P-selectin, which has been accepted as a key modulator of neutrophil infiltration in I/R kidney injury ([@B15]).

Our group also tested the therapeutic potential of traditional Chinese medicine in the treatment of AKI. We screened 10 kinds of Chinese herbal medicine with anti-inflammatory effects and found that wogonin and protocatechuic aldehyde had significant therapeutic effects. Wogonin inhibits cisplatin-induced renal damage by inhibiting RIPK1-mediated necroptosis and attenuates inflammation ([@B75]), whereas protocatechuic aldehyde (PA) not only inhibits necroptosis, but also effectively reduces cisplatin-induced over-production of ROS ([@B33]). Interestingly, we all know that cisplatin is commonly used as an anti-cancer drugs in clinic, and these two TCMs could even promote anti-tumor effects of cisplatin, so wogonin and protocatechuic aldehyde may be renoprotective adjuvants for cisplatin-based anticancer therapy.

There are many other TCMs to treat AKI, and these are listed in [Table 2](#T2){ref-type="table"}.

###### 

Application of TCM monomers in the treatment of acute kidney injury.

  Names                              Origins                                            Models                                  Functions                                                                              Mechanisms
  ---------------------------------- -------------------------------------------------- --------------------------------------- -------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Alpinetin                          *Alpinia katsumadai* Hayata                        LPS-induced AKI                         Inhibiting inflammation.                                                               By enhancing Nrf2 and HO-1 ([@B42])
  Astragaloside IV (AS-IV)           *Astragaloside*                                    Cisplatin-induced AKI                   Inhibiting oxidative damage and inflammatory response.                                 By activation of Nrf2 and suppression of NF-κB activation ([@B105])
  Astaxanthin (ATX)                  *Carotenoid in marine organisms*                   I/R, As~2~O~3~, HgCl~2~-induced AKI     Antioxidant activity; Inhibiting apoptosis.                                            By Akt/Bad/caspases pathway ([@B6]; [@B95]; [@B38]; [@B78])
  Baicalin                           *Scutellaria baicalensis*                          H~2~O~2~, -induced AKI                  Blocking oxidative stress, ER stress and apoptosis.                                    By activating Nrf2 signaling ([@B60])
                                                                                        Pb, pediatric sepsis -- induced AKI                                                                                            [@B126]
                                                                                        I/R-induced AKI                         Inhibiting inflammation and apoptosis.                                                 By inhibiting TLR2/4 and mitochondrial stress ([@B44])
                                                                                        LPS-induced AKI                                                                                                                By activating PPARγ and inhibiting NF-κB ([@B58])
  Breviscapine                       *Erigeron breviscapus*                             Cisplatin-induced AKI                   Inhibiting lipid peroxidation and ferroptosis.                                         By decreasing MDA, SOD, increasing glutathione peroxidase levels ([@B69])
  Chlorogenic Acid                   *Plant polyphenols*                                LPS-induced AKI                         Suppressing inflammation.                                                              By inhibiting TLR4/NF-κB signaling pathway ([@B111])
  *Cordyceps sinensis* (CS)          *An entomogenous fungus*                           I/R-induced renal injury                Inhibiting inflammation and apoptosis.                                                 By modulating SDF-1/CXCR4-signaling, reducing TLR-4,increasing HIF-1α ([@B130]; [@B118]; [@B90])
                                                                                        LPS-induced AKI                         Reducing autophagy and apoptosis.                                                      By reducing ED-1, GRP78 ([@B99])
  (CSP)                              *Cordyceps sobolifera*                             CsA -- induced AKI                      Suppressing apoptosis.                                                                 By enhancing TRMP6 and TRMP7 ([@B19])
  Curcumin                           *Curcuma longa*                                    Rhabdomyolysis (RM)-induced AKI         Reducing renal oxidative stress.                                                       By inhibiting AMPK and Nrf2/HO-1 ([@B98])
                                                                                        I/R-induced AKI                                                                                                                By NMDA receptor antagonism ([@B48])
                                                                                        Glycerol-induced AKI                    Ameliorating cell apoptosis.                                                           By activating the PI3K/Akt pathway ([@B98])
                                                                                        Cisplatin-induced AKI                   Preventing renal alterations. Inhibiting inflammatory.                                 By preventing mitochondrial bioenergetics and dynamic and SIRT3 levels ([@B76]). By inhibiting Mincle-maintained M1 macrophage phenotype ([@B86])
  Emodin                             *Rheum palmatum*                                   LPS-induced AKI                         Inhibiting inflammatory.                                                               By inhibiting TLR2 ([@B56]) or TLR4 ([@B133])
                                                                                        Cisplatin-induced AKI                   Inhibiting apoptosis and activating autophagy.                                         By modulating the AMPK/mTOR signaling ([@B63])
  Epigallocatechin gallate (EGCG)    *Green tea*                                        Contrast-induced AKI                    Alleviating apoptosis, oxidative stress and inflammation.                              By increasing HO-1 and Nrf2 ([@B34])
                                                                                        I/R, Cisplatin -induced AKI             Inhibiting inflammatory, Decreasing oxidative/nitrative stress.                        By activating HO-1 ([@B80]; [@B71]; [@B77])
                                                                                                                                Inhibiting apoptosis.                                                                  By preventing ERK ([@B135])
  Ginsenoside Rd (GSRd)              *Panax ginseng*                                    I/R-induced AKI                         Suppressing inflammatory.                                                              By inhibiting oxygen free radicals ([@B113])
                                                                                        Cisplatin-induced AKI                   Decreasing apoptosis.                                                                  [@B115]
                                                                                        Glycerol-induced AKI                    Reducing renal oxidative stress.                                                       [@B128]
  (Rb1, Rg1)                                                                            I/R-induced AKI                         Reducing apoptosis.                                                                    [@B132]
  (Rg1)                                                                                 Aldosterone- induced AKI                Reducing oxidative stress and autophagy.                                               By decreasing AMPK/mTOR pathway ([@B91])
  (Ginsenoside Rg3)                  *Panax ginseng*                                    Cisplatin-induced AKI                   Decreasing apoptosis.                                                                  By blocking the JNK-p53-caspase-3 signaling ([@B39])
                                                                                        LPS-induced AKI                         Decreasing inflammatory.                                                               By inhibiting NF-κB ([@B47])
  Esculentoside A (EsA)              *Phytolacca esculenta*                             LPS-induced AKI                         Alleviating inflammation.                                                              By activating PPAR-γ ([@B14])
                                                                                        Puncture-induced AKI                                                                                                           By regulating the TLR4/MyD88/HMGB1 signaling pathway ([@B85])
  Galangin                           *Propolis and Alpinia officinarum*                 Cisplatin-induced AKI                   Attenuating oxidative stress, inflammation, and cell death.                            By inhibiting ERK, NF-κB and RIPK1-mediated necroptosis signaling pathways ([@B43])
  Ginkgetin aglycone (GA)            *Ginkgo biloba extract*                            LPS-induced AKI                         Decreasing inflammatory.                                                               By activating SIRT1 via inhibiting the NF-κB signaling pathway ([@B121])
  Glycyrrhizic acid (GA)             *Ingredient in licorice*                           LPS-induced renal injury                Inhibiting cell apoptosis, oxidative stress.                                           By activating ERK and inhibiting NF-κB ([@B127])
                                                                                        I/R-induced renal injury                Reducing tubular necrosis.                                                             By inhibiting HMGB1 and enhancing Nrf2 ([@B53])
  (GA, 18βGA)                                                                           Cisplatin-induced AKI                   Inhibiting renal tubular epithelial cells apoptosis.                                   By enhancing BMP-7 epigenetically through targeting HDAC2 ([@B72])
                                                                                                                                Alleviating oxidative status and inflammatory.                                         [@B5]; [@B97]
  Gypenoside (GP)                    *Gynostemma pentaphyllum*                          I/R-induced renal injury                Attenuating inflammatory and oxidative stress.                                         By inhibiting ERK signaling ([@B112])
  Hyperin                            *Ericaceae*, *Guttifera*, and *Celastraceae*       Cisplatin-induced AKI                   Attenuating inflammatory.                                                              By inhibiting NF-κB and activating nuclear factor E2-related factor-2 signaling pathways ([@B11])
  Honokiol                           *Magnolia officinalis*                             LPS-induced AKI                         Inhibition of oxidative stress and Inflammation.                                       By inhibiting TLR2/4/MyD88 signaling pathway ([@B100])
  Isoacteoside (ISO)                 *Monochasma savatieri*                             LPS-induced AKI                         Attenuating inflammatory.                                                              By inhibiting TLR4 dimerization to activate the MyD88-TAK1- NF-κB/MAPK signaling cascades and TRIF pathway ([@B32])
  Leonurine (LEO)                    *Leonurus cardiaca*                                LPS-induced renal injury                Inhibiting inflammatory and oxidative stress.                                          By down-regulating NF-κB ([@B101])
  Ligustrazine (LIG)                 *Ligusticum wallichii* Franch.                     Cisplatin/I/R-induced renal injury      Down-regulating oxidative stress and apoptosis, decreasing neutrophils infiltration.   [@B68]; [@B28]
                                                                                        Pancreatitis-induced AKI                Improving renal function.                                                              By improve microcirculatory disorder (MCD) ([@B122])
  Loganetin                          *Loganin*                                          Rhabdomyolysis-induced AKI              Improving renal function.                                                              By inhibiting TLR4 activity and blocking the JNK/p38 pathway ([@B54])
  Luteolin                           *Celery*, *Green pepper*, *and Chamomile*          [D]{.smallcaps}-galactose-induced AKI   Attenuating inflammatory and oxidative stress.                                         By suppressing phosphorylation of p38 MAPK ([@B103])
                                                                                        Cisplatin-induced AKI                   Alleviating inflammation.                                                              By inhibiting NF-κB ([@B24])
                                                                                                                                Decreasing apoptosis.                                                                  By decreasing p53 ([@B46])
  Nerolidol                          *Essential oils*                                   LPS-induced AKI                         Alleviating inflammation.                                                              By inhibiting TLR4-NF-κB signal pathway ([@B123])
  Osthole                            *Cnidium monnieri* (L.) Cusson *fruit*             LPS-induced AKI                         Inhibiting inflammation.                                                               By down-regulating NF-κB pathway ([@B117])
                                                                                        I/R-induced renal injury                Abrogating inflammation.                                                               By suppressing JAK2/STAT3 signaling, NF-κB and activating PI3K/Akt signaling ([@B70])
  Pachymic acid (PA)                 *A lanostane-type triterpenoid from Poria cocos*   Sepsis-induced AKI                      Inhibiting inflammatory function and antioxidant effect via.                           By activating Nrf2/HO-1 pathway ([@B9])
  Paeonol                            *Paeonia moutan* Sims                              Endotoxin-induced AKI                   Alleviating inflammation.                                                              By inhibiting TLR4-NF-κB signal pathway ([@B26])
  *Panax quinquefolius* (PQS)        *Panax quinquefolius*                              Cisplatin-induced AKI                   Suppressing oxidative stress, inflammation, and apoptosis.                             By inhibiting Nox4-iNOS, NF-κB-COX-2, and caspase3/9 ([@B73])
  Paeoniflorin (PF)                  *Radix Paeoniae Rubra*                             Pancreatitis-induced AKI                Inhibiting inflammation and cell apoptosis.                                            By inhibiting NF-κB ([@B93])
                                                                                        ConA-induced renal injury               Attenuating inflammatory response.                                                     By inhibiting CXCR3/CXCL11 ([@B62])
  Panaxadiol Saponin (PDS)           *Ginseng stem and leaves*                          LPS-induced AKI                         Inhibiting inflammatory and oxidative stress.                                          By blocking NF-κB pathway ([@B17])
  Panax notoginseng saponins (PNS)   *Panax notoginseng*                                Cisplatin-induced AKI                   Reducing renal tissue apoptosis.                                                       By inhibiting the mitochondrial apoptosis ([@B66])
                                                                                                                                Increasing mitochondrial autophagy.                                                    By enhancing HIF-1α/BNIP3 ([@B67])
  Notoginsenoside R1 (NR1)                                                              I/R-induced renal injury                Blocking apoptosis and inflammatory response.                                          By suppressing p38 and NF-κB ([@B65])
  Polydatin (PD)                     *Polygonum cuspidatum* Sieb.                       I/R, Sepsis-induced AKI                 Attenuating inflammatory response                                                      By regulating TLR4/NF-κB and enhancing PI3K/Akt ([@B64])
  Protocatechuic Aldehyde (PA)       *Salvia miltiorrhiza* (*Lamiaceae*)                Cisplatin-induced AKI                   Suppressing Nox-mediated oxidative stress and renal inflammation.                      By suppressing Nox-mediated oxidative stress targeting RIPK1-mediated necroptosis ([@B33])
  Quercetin (QC)                     *Bioflavonoids in the plant kingdom*               I/R-induced AKI                         Activating autophagy                                                                   By increasing AMPK ([@B13])
                                                                                        HgCl~2~-induced AKI                     Limiting apoptosis.                                                                    [@B83]
                                                                                        Cisplatin-induced AKI                   Decreasing cell necrosis and inflammatory.                                             By inhibiting NF-κB ([@B29])
  RA-X II                            *Rubia yunnanensis*                                LPS-induced AKI                         Inhibiting oxidative stress and inflammatory.                                          By suppressing NF-κB and MAPKs regulated by HO-1/Nrf2 pathway ([@B4])
  Resveratrol (RSV)                  *Grapes and red wine*                              LPS-induced AKI                         Attenuating inflammatory response.                                                     By NF-B-P65 de-acetylation ([@B31])[,]{.ul} SIRT3-mediated deacetylation of SOD2 ([@B104]), inhibiting endoplasmic reticulum stress (IRE1)-activated NF-κB pathway ([@B92]) and via the activation of Nrf2 signaling pathway ([@B96])
                                                                                        Cisplatin-induced AKI                   Suppressing inflammation and apoptosis.                                                By activating SIRT1 through deacetylating p53 ([@B50])
                                                                                        Glycerol-induced AKI                    Suppressing inflammatory and lipid peroxidation.                                       By decreasing NF-κB and HO-1 ([@B22])
  (RSVA405 RSVA314)                                                                     As~2~O~3~, I/R -induced AKI             Antagonizing oxidative stress.                                                         [@B40]; [@B119]
  Tanshinone I                       *Salvia miltiorrhiza*                              AAI-induced renal injury                Inducing apoptosis and autophagy.                                                      By inducing Atg5 ([@B27])
  Tanshinone IIA                                                                        Folic Acid-induced AKI                  Inhibiting inflammatory response.                                                      [@B45]
  Tenuigenin (TNG)                   *Polygala tenuifolia*                              LPS-induced AKI                         Attenuating inflammatory response.                                                     Inhibiting TLR4/NF-κB signaling pathway ([@B30])
  Tetramethylpyrazine (TMP)          *Ligusticum wallichii* Franch.                     Arsenic, Cisplatin-induced AKI          Inhibiting inflammatory and oxidative stress.                                          By down-regulating HO-1 and ARS2 ([@B36])
                                                                                        Gentamicin-induced AKI                  Inhibiting inflammatory and apoptosis.                                                 By enhancing Hax-1 and HO-1 ([@B84])
                                                                                        Sodium arsenite-induced AKI             Suppressing ROS production, mitochondrial dysfunction and inflammatory.                By suppressing programmed cell death ([@B35])
                                                                                        Contrast-induced AKI                    Suppressing autophagy and apoptosis.                                                   By suppressing p38 MAPK and targeting FoxO1 ([@B37])
                                                                                        I/R-induced renal injury                Alleviating histopathological damage.                                                  By down-regulating P-selectin ([@B15])
  Triptolide (PG490-88)              *Tripterygium wilfordii* Hook.F                    Cisplatin-induced AKI                   Decreasing cell necrosis.                                                              By decreasing phosphorylation of ERK ([@B51])
  Wogonin                            *Scutellaria baicalensis* Georgi                   Cisplatin-induced AKI                   Attenuating inflammatory response.                                                     By targeting RIPK1-mediated necroptosis ([@B75])
                                                                                                                                                                                                                       

Mechanisms Involved in the Therapeutic Effect of TCMs in AKI
------------------------------------------------------------

As shown in [Figure 1](#F1){ref-type="fig"}, the TGF-β receptor, Toll-like receptors (TLRs), TNF receptor, and FASL/Death receptors are stimulated by LPS, cisplatin and I/R, etc., then these receptors activate downstream pathways, further triggering ROS production and inflammatory responses, eventually leading to kidney damage. TCMs suppress cisplatin/LPS/I/R-stimulated TLRs including TLR2/4, or by activating PPAR, further inhibiting the NF-κB pathway and reducing inflammation. Moreover, TCMs reduce apoptosis by inhibiting TGF-β, PI3K/AKT and ERK/JNK/P38MARK pathways. In addition, TCMs inhibit autophagy by targeting AMPK/mTOR. In recent years, new cell death mechanisms like programmed necrosis and ferroptosis have also attracted attention. Wogonin and protocatechuic aldehyde can effectively inhibit RIPK1/RIPK3-mediated necroptosis. Breviscapine can reduce ferroptosis by increasing glutathione peroxidase levels. Additionally, TCMs can inhibit H~2~O~2~-induced endoplasmic reticulum (ER) stress and further reduce ROS production. In the AKI model, ROS, HMGB1, P53, Nrf2, HO-1, and SIRT1/3 are regarded as potential therapeutic targets of TCMs.

![The molecular pathways targeted by the TCMs covered in this review are summarized. TGF-β receptor, Toll-like receptors (TLRs), TNF receptor, and FASL/Death receptors are stimulated by LPS, cisplatin, I/R, etc. These receptors are then activated by the downstream pathway, further triggering ROS production and an inflammatory response, eventually leading to kidney damage. TCMs suppress cisplatin/LPS/I/R-stimulated Toll-like receptors (TLR2/4), or by activating PPAR-γ, further inhibiting the NF-κB pathway and reducing inflammation. Additionally, apart from targeting caspase3/9, TCMs reduce apoptosis by inhibiting the TGF-β receptor, the ERK/JNK/P38MARK pathway and by promoting PI3K/AKT. In addition, TCMs inhibit autophagy by targeting inhibition of AMPK/mTOR. In addition to the traditional apoptosis, autophagy, programmed necrosis and ferroptosis are also caused during AKI. Wogonin and protocatechuic aldehyde can effectively inhibit RIPK1 in the RIPK1/RIPK3/MLKL of necroptosis. TLR2/4-mediated TRAF2 has a stimulant effect on RIPK3. Induction of HMGB2 by necroptosis and TLR2/4-regulated MyD88 aggravates the inflammatory response of acute kidney injury, while TCMs significantly improve this phenomenon via direct or indirect effects. Breviscapine can reduce ferroptosis by increasing glutathione peroxidase levels. In acute kidney injury, the production of ROS, the multiple roles of P53, the protective effects of eNOS, Nrf2, HO-1, and SIRT1/3 all become therapeutic targets of TCMs.](fphar-10-00376-g001){#F1}

Nephrotoxicity of TCMs
----------------------

It has been recorded that up to 25% of all cases of AKI may be correlated to nephrotoxic medications ([@B7]). As shown in [Table 3](#T3){ref-type="table"}, previous studies indicate that some TCMs, including aristolochic acid, anthraquinones, flavonoids, and glycosides from herbs, non-steroidal anti-inflammatory drugs, aminoglycosides, cytostatic drugs, osmotic agents, radiocontrast, and phosphate salts, may lead to kidney damage and induce AKI ([@B57]; [@B106]). Several reasons contributing to nephrotoxicity of TCMs include the intrinsic toxicity of herb medicines, incorrect dosing, interactions between herbs and medications, adulteration, incorrect processing and storage, and contamination by heavy metals ([@B106]).

###### 

Application of TCM monomers which can induce acute kidney injury.

  Names                     Origins                                          Functions                                                          Mechanisms
  ------------------------- ------------------------------------------------ ------------------------------------------------------------------ ------------------------------------------------------------------
  Aristolochia acids (AA)   *Aristolochia species*                           Increasing oxidative stress and inflammatory                       Increasing Nox2 and reducing NO bioavailability ([@B82]; [@B20])
  Andrographide             *A herbaceous plant in the family Acanthaceae*   Promoting cell necrosis                                            Unclear ([@B124])
  Sciadopitysin             *Taxus celebica*                                 Inducing acute tubular necrosis and acute interstitial nephritis   ([@B59])
  Triptolide                *Tripterygium wilfordii* Hook.f                  Accelerating oxidative stress and inducing apoptosis               Inducing production of ROS ([@B107])
                                                                                                                                                

It was reported that two patients took sciadopitysin, a kind of flavonoid extracted from *Taxus celebica* to treat diabetes mellitus, and suffered acute tubular necrosis and acute interstitial nephritis ([@B59]). Andrographolide (Chuan Xin Lian) is widely used in China for the treatment of dysentery and respiratory tract infection. It is noteworthy that a systemic analysis, based on clinical cases reported in Chinese literature from January 1978 to August 2013, revealed 26 patients with AKI induced by andrographolide. The major pathologic features in these patients were acute tubular necrosis. The mechanism is still obscure ([@B124]). Aristolochia acids (AA) is extracted from *Aristolochia fangchi*, within which aristolochic acid I (AAI) and aristolochic acid II (AAII) are well known. AA has widely been used as an anti-inflammatory agent. However, a series of studies demonstrated that AA could induce early and transient acute tubular necrosis and progressive tubulointerstitial injury, which finally lead to renal fibrosis ([@B82]; [@B20]; [@B129]; [@B21]). AA also caused nephropathy, by inducing DNA adduct formation ([@B2]). Some drugs related with AA are nephrotoxic due to the intrinsic toxicity of herbs and the misidentification of potentially toxic compounds. The root of asarum (also known as Xi Xin) contains low levels of AA and has widely been used as an analgesic for headache, toothache, and inflammatory diseases. But the whole asarum plant contains high levels of AA ([@B25]). Triptolide, isolated from *Tripterygium wilfordii* Hook.f (TWHf)-derived diterpenoid, has been commonly used for its immunosuppressive and anti-cancer properties ([@B10]). However, administration of triptolide may result in severe kidney injury by impairing the antioxidant system, promoting production of reactive oxygen species and inducing apoptosis of tubular epithelial cells, which may limit the application of triptolide in the clinic ([@B108], [@B107]).

Prevention and Treatment of TCMs-Induced AKI
--------------------------------------------

The first principle of effective therapy is to acknowledge and prevent or minimize nephrotoxicity of TCMs. In this regard, several strategies should be applied: (1) In view of the intrinsic toxicity of some herbs, researchers could modify molecular structure of TCMs to lower the toxic effects without affecting their therapeutic effects. It is essential to reveal the compound/phytochemicals present in the formulations which are correlated with the toxicity in AKI. (2) As for the incorrect identification, processing and storage, standardization of herbal products need to be emphasized. We should also ensure safe manufacturing processes to avoid contamination from heavy metals and other ingredients. (3) We should determine and limit the dosing and duration of drugs usage through adequate preclinical trials and dose conversions between animals and humans. Safe and effective dose ranges for humans as well as appropriate monitoring for adverse effects are also needed. (4) It is worth mentioning that pharmacists and doctors should clearly know the interactions between TCMs and other medications before prescribing these drugs to patients. (5) For patients with special conditions, like chronic kidney disease and liver disease, their medication needs to be carefully considered.

Conclusion and Perspectives
===========================

Collectively, previous studies showed that numerous types of TCMs protect against AKI via different mechanisms of action, including inhibiting inflammation, cell apoptosis, necroptosis, ferroptosis, and restraining oxidative stress etc. These data support the potential application of these TCMs as novel therapeutic agents in treating patients with AKI. Although some TCMs have entered preclinical trials, it is essential to initiate pre-clinical pharmacologic and toxicologic trials and clinical trials to evaluate the efficacy and safety of TCMs usage. Moreover, considering that some TCMs are deleterious to the kidney, they should be attracted more attention when utilized. In addition, it is believed that western medicines always relieve symptoms quickly while TCMs exert therapeutic effects gently and fundamentally. In this regard, the combination of TCMs and western medicines may become a promising treatment strategy for AKI by taking advantages of both and by limiting side effects. The interaction between medicines should also be considered. In conclusion, from a holistic point of view, TCM-based anti-AKI therapy should be emphasized and extensively explored, as this may help to minimize the morbidity and mortality of AKI and prolong the survival of patients.
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AKI

:   acute kidney injury

ER stress

:   endoplasmic reticulum stress

ERK

:   extracellular signal-regulated kinase

HMGB1

:   high mobility group box 1

HO-1

:   heme oxygenase (HO)-1

i.p.

:   intraperitoneal

I/R

:   ischemic reperfusion

JNK

:   C-jun N-terminal kinase

LPS

:   lipopolysaccharide

MLKL

:   mixed-lineage kinase like domain

Nrf2

:   nuclear factor 2 correlation factor

PI3K/AKT

:   phosphatidylinositol 3-hydroxy kinase/protein kinase

PPAR-γ

:   peroxisome proliferators-activated receptor-γ

RIPK

:   receptor interacting serine-threonine protein kinase

ROS

:   reactive oxygen species

SIRT

:   silent information regulator

TCMs

:   traditional Chinese medicines
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